Connection
Cecilia Low Wang to Risk Assessment
This is a "connection" page, showing publications Cecilia Low Wang has written about Risk Assessment.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.105 |
|
|
|
-
Low Wang CC, Everett BM, Burman KD, Wilson PWF. Cardiovascular Safety Trials for All New Diabetes Mellitus Drugs? Circulation. 2019 04 02; 139(14):1741-1743.
Score: 0.074
-
Khan SS, Bhave N, Blumenthal RS, Coresh J, Huang X, Joseph JJ, Khera A, Ho JE, Lloyd-Jones DM, Low Wang CC, Lu Y, Morris PB, Nasir K, Natarajan P, Rangaswami J, Rodriguez F, Sperling LS, Virani SS, Zhang S, Ndumele CE. Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2026 Jul 28; 154(4):e159-e180.
Score: 0.031